Used in pharmaceutical synthesis as a chiral intermediate for developing kinase inhibitors, particularly in oncology research. Its oxazole core and cyclopropylpyridine moiety enhance binding selectivity to specific enzyme targets. Commonly employed in the preparation of small-molecule therapeutics targeting solid tumors. Also utilized in asymmetric synthesis due to its stereochemical stability, enabling high enantiomeric purity in final drug compounds.